Treace Medical Concepts, Inc. (TMCI) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TMCI Revenue Growth
TMCI Revenue Analysis (2019–2025)
As of May 8, 2026, Treace Medical Concepts, Inc. (TMCI) generated trailing twelve-month (TTM) revenue of $212.7 million, reflecting moderate decline in growth of -9.0% year-over-year. The most recent quarter (Q4 2025) recorded $62.5 million in revenue, up 24.5% sequentially.
Looking at the longer-term picture, TMCI's 5-year compound annual growth rate (CAGR) stands at +30.0%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $212.7 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including ANGO (+7.3% YoY), NVCR (+8.5% YoY), and ATEC (-7.4% YoY), TMCI has underperformed the peer group in terms of revenue growth. Compare TMCI vs ANGO →
TMCI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TMCICurrent | $213M | -9.0% | +30.0% | -25.5% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ATEC | $764M | -7.4% | +39.5% | -10.7% | |
 OSUR | $115M | -47.3% | -7.7% | -59.2% | |
 PRCT | $308M | +29.3% | +109.0% | -33.7% |
TMCI Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $212.7M | +1.6% | $169.8M | 79.8% | $-54,154,000 | -25.5% |
| 2024 | $209.4M | +11.9% | $168.3M | 80.4% | $-55,688,000 | -26.6% |
| 2023 | $187.1M | +31.9% | $151.9M | 81.2% | $-51,428,000 | -27.5% |
| 2022 | $141.8M | +50.2% | $114.3M | 80.6% | $-34,844,000 | -24.6% |
| 2021 | $94.4M | +64.6% | $77.5M | 82.1% | $-16,510,000 | -17.5% |
| 2020 | $57.4M | +45.5% | $44.9M | 78.3% | $855K | 1.5% |
| 2019 | $39.4M | - | $31.8M | 80.6% | $-3,535,000 | -9.0% |
See TMCI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TMCI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TMCI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTMCI — Frequently Asked Questions
Quick answers to the most common questions about buying TMCI stock.
Is TMCI's revenue growth accelerating or slowing?
TMCI revenue declined -9.0% year-over-year, contrasting with the 5-year CAGR of +30.0%. TTM revenue fell to $213M. This reverses the prior growth trend.
What is TMCI's long-term revenue growth rate?
Treace Medical Concepts, Inc.'s 5-year revenue CAGR of +30.0% reflects the variable expansion pattern. Current YoY growth of -9.0% is below this long-term average.
How is TMCI's revenue distributed by segment?
TMCI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.